Clinical Trial Update: Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 [Phase 1]

View source ↗

Summary

This report summarizes the completion of a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of AZD1386 in people with chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• AZD1386 (Capsaicin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED